Literature DB >> 15343379

Stat3 is required for the development of skin cancer.

Laura Pedranzini1, Andrea Leitch, Jacqueline Bromberg.   

Abstract

Signal transducer and activator of transcription 3 (Stat3) is a transcription factor that is constitutively activated in a variety of human malignancies, including prostate, lung, brain, breast, and squamous cell carcinomas. Inhibition of activated Stat3 leads to decreased proliferation and apoptosis of many cancer-derived cell lines, while the introduction of a constitutively activated form of Stat3 into immortalized human breast epithelial cells and rodent fibroblasts results in cellular transformation. Collectively, these data suggest a role for Stat3 in oncogenesis. A new study from Chan et al. is the first to demonstrate a requirement for Stat3 in de novo epithelial carcinogenesis in vivo. Using the two-step model of chemically induced skin carcinogenesis, the authors demonstrated that mice deficient in Stat3 were completely resistant to skin tumor development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15343379      PMCID: PMC514594          DOI: 10.1172/JCI22800

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis.

Authors:  Paul A Townsend; Tiziano M Scarabelli; Sean M Davidson; Richard A Knight; David S Latchman; Anastasis Stephanou
Journal:  J Biol Chem       Date:  2003-11-05       Impact factor: 5.157

2.  Defining the epithelial stem cell niche in skin.

Authors:  Tudorita Tumbar; Geraldine Guasch; Valentina Greco; Cedric Blanpain; William E Lowry; Michael Rendl; Elaine Fuchs
Journal:  Science       Date:  2003-12-11       Impact factor: 47.728

3.  Suppression of the TPA-induced expression of nuclear-protooncogenes in mouse epidermis by crocetin via antioxidant activity.

Authors:  J D Hsu; F P Chou; M J Lee; H C Chiang; Y L Lin; S J Shiow; C J Wang
Journal:  Anticancer Res       Date:  1999 Sep-Oct       Impact factor: 2.480

4.  Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.

Authors:  G Niu; R Heller; R Catlett-Falcone; D Coppola; M Jaroszeski; W Dalton; R Jove; H Yu
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

5.  Roles of activated Src and Stat3 signaling in melanoma tumor cell growth.

Authors:  Guilian Niu; Tammy Bowman; Mei Huang; Steve Shivers; Douglas Reintgen; Adil Daud; Alfred Chang; Alan Kraker; Richard Jove; Hua Yu
Journal:  Oncogene       Date:  2002-10-10       Impact factor: 9.867

6.  Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth.

Authors:  Paul L Leong; Genevieve A Andrews; Daniel E Johnson; Kevin F Dyer; Sichuan Xi; Jeffrey C Mai; Paul D Robbins; Seshu Gadiparthi; Nancy A Burke; Simon F Watkins; Jennifer Rubin Grandis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-14       Impact factor: 11.205

7.  Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.

Authors:  Ellen J Schlette; L Jeffrey Medeiros; Andre Goy; Raymond Lai; George Z Rassidakis
Journal:  J Clin Oncol       Date:  2004-05-01       Impact factor: 44.544

8.  Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.

Authors:  Keith Syson Chan; Steve Carbajal; Kaoru Kiguchi; John Clifford; Shigetoshi Sano; John DiGiovanni
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

9.  Capturing and profiling adult hair follicle stem cells.

Authors:  Rebecca J Morris; Yaping Liu; Lee Marles; Zaixin Yang; Carol Trempus; Shulan Li; Jamie S Lin; Janet A Sawicki; George Cotsarelis
Journal:  Nat Biotechnol       Date:  2004-03-14       Impact factor: 54.908

10.  Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility.

Authors:  Debra L Silver; Honami Naora; Jinsong Liu; Wenjun Cheng; Denise J Montell
Journal:  Cancer Res       Date:  2004-05-15       Impact factor: 12.701

View more
  30 in total

1.  Investigation into the biological properties of the olive polyphenol, hydroxytyrosol: mechanistic insights by genome-wide mRNA-Seq analysis.

Authors:  Haloom Rafehi; Andrea J Smith; Aneta Balcerczyk; Mark Ziemann; Jenny Ooi; Shanon J Loveridge; Emma K Baker; Assam El-Osta; Tom C Karagiannis
Journal:  Genes Nutr       Date:  2011-09-28       Impact factor: 5.523

2.  Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1: potential role in proliferation and apoptosis.

Authors:  Sahdeo Prasad; Manoj K Pandey; Vivek R Yadav; Bharat B Aggarwal
Journal:  Cancer Prev Res (Phila)       Date:  2011-04-13

3.  Platelet-rich plasma increases proliferation of tendon cells by modulating Stat3 and p27 to up-regulate expression of cyclins and cyclin-dependent kinases.

Authors:  T-Y Yu; J-H S Pang; K P-H Wu; L-P Lin; W-C Tseng; W-C Tsai
Journal:  Cell Prolif       Date:  2015-05-25       Impact factor: 6.831

4.  Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.

Authors:  Malabika Sen; Sonali Joyce; Mary Panahandeh; Changyou Li; Sufi M Thomas; Jessica Maxwell; Lin Wang; William E Gooding; Daniel E Johnson; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2012-07-23       Impact factor: 12.531

Review 5.  Histone modifiers: Dynamic regulators of the cutaneous transcriptome.

Authors:  Kanad Ghosh; Kyle O'Neil; Brian C Capell
Journal:  J Dermatol Sci       Date:  2017-12-18       Impact factor: 4.563

6.  STAT3 negatively regulates thyroid tumorigenesis.

Authors:  Joana Pinto Couto; Laura Daly; Ana Almeida; Jeffrey A Knauf; James A Fagin; Manuel Sobrinho-Simões; Jorge Lima; Valdemar Máximo; Paula Soares; David Lyden; Jacqueline F Bromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

7.  LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression.

Authors:  Ja Eun Kim; Hong Sook Kim; Yong Jae Shin; Chang Seok Lee; Cheolhee Won; Sin Ae Lee; Jung Weon Lee; Youngsoo Kim; Jae Seung Kang; Sang Kyu Ye; Myung Hee Chung
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

8.  Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression.

Authors:  Emily C Brantley; L Burton Nabors; G Yancey Gillespie; Youn-Hee Choi; Cheryl Ann Palmer; Keith Harrison; Kevin Roarty; Etty N Benveniste
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

9.  Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function.

Authors:  George Z Cheng; Wei Zhou Zhang; Mei Sun; Qi Wang; Domenico Coppola; Mena Mansour; Li Mei Xu; Carliann Costanzo; Jin Q Cheng; Lu-Hai Wang
Journal:  J Biol Chem       Date:  2008-03-19       Impact factor: 5.157

10.  Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.

Authors:  Uksha Saini; Shan Naidu; Adam C ElNaggar; Hemant Kumar Bid; John J Wallbillich; Kristin Bixel; Chelsea Bolyard; Adrian A Suarez; Balveen Kaur; Periannan Kuppusamy; John Hays; Paul J Goodfellow; David E Cohn; Karuppaiyah Selvendiran
Journal:  Oncogene       Date:  2016-06-13       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.